Bryan Li
Impact in
-
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Glioma Diagnosis and Treatment
Papers in
- Genetics 10
- Glioma Diagnosis and Treatment 10
-
- Chromatin Remodeling and Cancer 4
- Renal and related cancers 3
- Hedgehog Signaling Pathway Studies 2
- Co-authors
- Meredith S. Irwin (2 shared papers)Andreas Stolcke (1 shared paper)Dimitrios Dimitriadis (1 shared paper)Ian R. Watson (1 shared paper)Àngel Blanch (1 shared paper)Michael Ohh (1 shared paper)O. Roche (1 shared paper)Roland Leung (5 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Neuro-Oncology (4 papers)Current Oncology Reports (1 paper)Acta Neuropathologica Communications (1 paper)Expert Review of Molecular Diagnostics (1 paper)
- Partner nations
- CanadaUnited StatesHong Kong
In The Last Decade
Bryan Li
19 papers receiving 214 citations
Peers
Comparison fields: 5 of 53
- Hepatology 33
- Genetics 43
- Oncology 68
- Neurology 35
- Cancer Research 23
Countries citing papers authored by Bryan Li
This map shows the geographic impact of Bryan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Li more than expected).
Fields of papers citing papers by Bryan Li
This network shows the impact of papers produced by Bryan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Li. The network helps show where Bryan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Bryan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 47 | |
| 2 | 2021 | 36 | |
| 3 | 2019 | 33 | |
| 4 | 2021 | 19 | |
| 5 | 2016 | 17 | |
| 6 | 2020 | 13 | |
| 7 | 2018 | 12 | |
| 8 | 2021 | 9 | |
| 9 | 2020 | 7 | |
| 10 | 2022 | 5 | |
| 11 | 2020 | 5 | |
| 12 | 2025 | 3 | |
| 13 | 2023 | 3 | |
| 14 | 2019 | 3 | |
| 15 | 2021 | 2 | |
| 16 | 2019 | 2 | |
| 17 | 2020 | 1 | |
| 18 | 2020 | 1 | |
| 19 | 2022 | 1 |
About Bryan Li
Bryan Li is a scholar working on Genetics, Molecular Biology, Oncology, Hepatology and Neurology, having authored 19 papers that have together received 219 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Chromatin Remodeling and Cancer (4 papers), Renal and related cancers (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Neuroblastoma Research and Treatments (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Hedgehog Signaling Pathway Studies (2 papers). The work is most often cited by research in Hepatology (33 citations), Genetics (43 citations), Oncology (68 citations), Neurology (35 citations) and Cancer Research (23 citations). Bryan Li has collaborated with scholars based in Canada, United States and Hong Kong. Frequent co-authors include Meredith S. Irwin, Andreas Stolcke, Dimitrios Dimitriadis, Ian R. Watson, Àngel Blanch, Michael Ohh, O. Roche, Roland Leung, Annie Huang and Joanne Wing Yan Chiu. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Current Oncology Reports, Acta Neuropathologica Communications and Expert Review of Molecular Diagnostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.